SCHEMBL2063371

SCHEMBL2063371

CCC(=O)N[C@H]1CCCCC1n1c(-c2ccccc2)c(C(=O)N2CCNCC2)n(Cc2cccc(OC(C(N)=O)C(C)C)c2)c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR8 P51685 4/20 0.37
APP P05067 6/20 0.32
MMP1 P03956 1/20 0.32
MMP2 P08253 1/20 0.32
MMP7 P09237 1/20 0.32
MMP10 P09238 1/20 0.32
MMP9 P14780 1/20 0.32
MMP13 P45452 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
MMP14 P50281 1/20 0.32
ADAM17 P78536 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2062020 0.89 KMT2A (0.41) CCR8KMT2AALDH1A1KDM4EMEN1
SCHEMBL2062618 0.89 CCR8 (0.47) CCR8APPMMP1MMP2MMP7
SCHEMBL2062570 0.88 CCR8 (0.39) CCR8KMT2AALDH1A1KDM4EMEN1
SCHEMBL2063373 0.88 CCR8 (0.37) CCR8KMT2AALDH1A1USP2CYP1A2
SCHEMBL2063134 0.87 CCR8 (0.37) CCR8KMT2AALDH1A1KDM4EMEN1
SCHEMBL10224836 0.86 CHRM3 (0.36) CCR8ALDH1A1MLNRCHRM3
SCHEMBL2063265 0.86 CCR8 (0.38) CCR8KMT2AALDH1A1KDM4EMEN1
SCHEMBL884353 0.86 CCR8 (0.38) CCR8KMT2AALDH1A1KDM4EMEN1
SCHEMBL2063854 0.85 CCR8 (0.37) CCR8KMT2AALDH1A1MEN1LMNA
SCHEMBL884664 0.84 ROCK2 (0.36) CCR8KMT2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148367-B2 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-03 US claimed
US-20100105665-A1 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-29 US claimed
US-8148367-B2 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-03 US disclosed
US-20100105665-A1 RENIN INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105665-A1 RENIN INHIBITORS REN, ACE, AGT CCR8 3694/4885APP 595/4885MMP1 183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.